Page last updated: 2024-10-25

cimetidine and Inflammatory Bowel Diseases

cimetidine has been researched along with Inflammatory Bowel Diseases in 1 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Inflammatory Bowel Diseases: Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fogel, W1
LewiƄski, A1
Jochem, J1

Reviews

1 review available for cimetidine and Inflammatory Bowel Diseases

ArticleYear
Histamine in idiopathic inflammatory bowel diseases--not a standby player.
    Folia medica Cracoviensia, 2005, Volume: 46, Issue:3-4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cimetidine; Crohn Disease; Histamine; Histamine An

2005